| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,,||,
*
Joint Program in Transfusion Medicine, Children’s Hospital, and Harvard Medical School, Department of Pathology, Boston, MA 02115;
Laboratory of Immunology and Vascular Biology, Department of Pathology, and the Digestive Disease Center, Department of Medicine, Stanford University Medical School, Stanford, CA 94305;
Center for Molecular Biology and Medicine, Veterans Affairs, Palo Alto Health Care System, Palo Alto, CA 94304;
Millennium Pharmaceuticals, Inc., Cambridge, MA 02142;
¶
Division of Respiratory Medicine, Institute for Lung Health, Leicester University Medical School, Leicester, United Kingdom; and Departments of
||
Microbiology and Immunology,
#
Surgery,
**
Functional Restoration, and
Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA 94305
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
4
7 integrin) required for homing to
nonlymphoid tissues. A subset of CD27(neg) memory CD4 T cells from
human peripheral blood is greatly enriched in the CCR7(neg) population,
as well as L-selectin(neg) cells, suggesting that these cells are
incapable of homing to secondary lymphoid organs. Accordingly,
CD27(neg) T cells are rare within tonsil, a representative secondary
lymphoid organ. All resting T cells within secondary lymphoid organs
express high levels of CCR7, but many activated cells lack CCR7.
CCR7 loss in activated CD4 cells accompanies CXC chemokine receptor
(CXCR)5 gain, suggesting that the reciprocal expression of these two
receptors may contribute to differential positioning of resting vs
activated cells within the organ. Lymphocytes isolated from nonlymphoid
tissues (such as skin, lung, or intestine) contain many CD27(neg) cells
lacking CCR7. The ratio of CD27(neg)/CCR7(neg) cells to
CD27(pos)/CCR7(pos) cells varies from tissue to tissue, and may
correlate with the number of cells actively engaged in Ag recognition
within a given tissue. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Along with lymphocyte adhesion molecules, chemokines and their receptors appear to play vital roles in the trafficking cycle of lymphocytes during inflammation and routine immunosurveillance (Refs. 2, 3 ; reviewed in Ref. 4). CCR7 is a very important player in the mechanism by which T lymphocytes enter secondary lymphoid organs through high endothelial venule(s) (HEV).4 T cells unable to receive a signal through CCR7 do not adhere to HEV after the initial tethering and rolling process begins; hence, they are unable to enter lymph nodes or Peyer’s patches (Refs. 5, 6 ; reviewed in Ref. 4). Mice lacking the CCR7 gene form small, disorganized lymphoid tissues containing very few T or B cells (7).
Ligands for CCR7 are expressed by the HEV of secondary lymphoid organs (5, 6, 8), by parenchymal cells within T zones of lymph nodes (8), and by endothelial cells at the openings of lymphatic vessels within peripheral tissues (8). In addition, CCR7 expression (or lack thereof) defines a subset of peripheral blood CD4 cells enriched in cells of unique "effector" phenotype (9).
Thus, due to the apparent biological significance of this molecule, we found it of great importance to fully characterize the expression of CCR7 on T lymphocytes during all identifiable phases of T lymphocyte trafficking. We have recently generated a series of anti-CCR7 mAbs, two of which recognize epitopes that correlate directly with functional responsiveness to CCR7 ligands. We report our findings with these new Abs below.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
L1/2 cells were transfected with human CCR7 and used to immunize mice. mAbs to CCR7 were generated as described (10) (the mAbs were produced and purified by the staff of Millennium Pharmaceuticals, Cambridge, MA).
mAbs that recognized CCR7 transfectants but not wild-type L1/2 cells
were tested against the following panel of L1/2 cells transfected with
various other known (or suspected) chemokine receptors: CCR1, CCR2,
CCR3, CCR4, CCR5, CCR6, CCR8, CCR9, CXC chemokine receptor (CXCR) 1,
CXCR2, CXCR3, CXCR4, CXCR5, CX3CR1, CR1, Bonzo, BOB, APJ, RDC,
AF014958, and LyGPR. No appreciable cross-reactivity was observed for
any of these receptor transfectants. Several clones specific for CCR7
transfectants were derived, and a few of them, including 7H12 (murine
IgG2b) and 3D9 (murine IgM), recognized a proportion of PBLs nearly
identical with the proportion capable of responding to known CCR7
ligands. These two mAbs gave essentially identical staining patterns on
all lymphocyte subsets tested, and only these clones were used for the
studies reported here. The staining patterns of these two novel mAbs
were very similar to that of the CCR7 mAb used in Ref. 9
on T cells. In further support of the specificity of these mAbs for
CCR7, the ability to stain PBLs with the 7H12 and 3D9 mAbs was lost
after treatment with the CCR7 ligand macrophage-inflammatory protein
(MIP)-3, but not after treatment with the CXCR4 ligand stromal
cell-derived factor (SDF)-1 (J.J.C., unpublished data). Thus,
MIP-3 may either directly block binding of the mABs to their cell
surface epitope or cause internalization of their cell surface epitope
(directly or indirectly). Indirect triggering of internalization seems
unlikely, as in the reciprocal experiment pretreatment of PBL with the
CXCR4 ligand SDF-1 abolished binding of two commercially available
anti-CXCR4 mAbs without affecting the binding of our CCR7 mAbs
(J.J.C., unpublished data).
Four-color flow cytometry
Four-color flow cytometry was performed as in Ref.
2 . mAbs were either directly conjugated to FITC, PE, or
APC, or visualized with biotinylated horse anti-mouse IgG (Vector
Laboratories, Burlingame, CA) followed by streptavidin-peridinin
chlorophyll protein (Becton Dickinson, San Jose, CA). Purified Igs from
the following hybridoma clones were used:
47 integrin (ACT-1),
CCR5 (2D7), CD4 (RPA-T4), CD8 (RPA-T8), CD11B/MAC-1 (BEAR-1), CD27
(M-T271), CD45RA (HI-100), CD62L/L-selectin (DREG-56), CD69 (FN50), and
cutaneous lymphocyte Ag (CLA) (HECA-452),
Chemotaxis
All migration assays were performed in Costar 24-well plate tissue-culture inserts with 5-µm-pore polycarbonate filters. Cells (5 x 105) were placed in the upper chamber in 100 µl, and 600 µl of a given chemokine dilution was placed in the lower well. Migration was carried out in migration medium (RPMI 1640/0.5% BSA fraction V; Sigma, St. Louis, MO). Migrated cells were counted as described previously (2, 11, 12, 13, 14). Migrating cells were kept at 37°C with 8% CO2.
MIP-3 was synthesized by one of us (D.S.) or purchased in
recombinant form from PeproTech (Rocky Hill, NJ). Both synthetic and
recombinant forms behaved identically in parallel experiments.
Recombinant secondary lymphoid-tissue chemokine (SLC) was purchased
from PeproTech. Synthetic SDF-1 was purchased from Gryphon Sciences
(South San Francisco, CA). Recombinant Burkit’s lymphoma receptor-1
ligand chemokine (BCL-1) was purchased from R&D Systems
(Minneapolis, MN).
Human peripheral blood and tissue lymphocytes
Human peripheral blood was collected in heparinized tubes from healthy donors. Granulocytes were removed as described (15). Monocytes were removed by two 30-min rounds of adherence to a T-175 culture flask (Nunc, Roskilde, Denmark) at 37°C and 8% CO2 in RPMI 1642 medium supplemented with 10% calf serum. Fresh tonsils were obtained after routine adenoid and tonsillectomy procedures. Tonsil lymphocytes were dispersed through stainless steel mesh and incubated in the same way as PBL above to remove adherent cells.
Normal human jejunum, lung, facial skin, inflamed liver, and inflamed synovial tissue were obtained from patients undergoing various surgical procedures. Synovial fluid was obtained from patients undergoing diagnostic arthroscopy. Bronchial alveolar lavage cells were obtained by fiber optic bronchoscopy. Subjects were premedicated with nebulized salbutamol before being lightly sedated with midazolam, and the upper airway was anesthetized with 2% lignocaine. Normal saline (180 ml) was inserted through the bronchoscope into the right lower lobe and aspirated using gentle suction. Recovery was between 20 and 46%.
Lymphocytes from the lamina propria of human jejunum were isolated as
described previously (16) with slight modification (i.e.,
the DTT step to degrade mucous was eliminated because we found that DTT
destroyed the epitopes recognized by the
anti-47 mAb
ACT-1). Lymphocyte yield was not reduced by eliminating this step (data
not shown). Lymphocytes were isolated from normal human skin by first
using a razor blade to separate the epidermis and a portion of the
dermis from the lower dermis and s.c. fat. The epidermal pieces were
cut into strips and incubated in cold 5 mM EDTA/HBSS for 120 min with
vigorous stirring. The supernatant from this step was spun down to
obtain released lymphocytes, and the remaining strips were crushed
through a 50-µm pore size strainer to obtain additional lymphocytes.
Lymphocytes were isolated from normal lung by finely mincing the tissue
and sieving the resulting suspension through gauze. Lymphocytes were
isolated from explant livers by first cutting the liver into small
1-cm2 pieces, washing in RPMI 1640 supplemented
with 10% FBS, then homogenizing into a cell suspension with a
Stomacher 400 (Seward, London, U.K.). Lymphocytes were isolated from
synovial tissue by mincing and treating with EDTA as described above
for epidermis. Synovial fluid and bronchoalveolar lavage fluid were
diluted with FACS buffer (PBS supplemented with 0.1% azide and 1%
BSA), centrifuged at 250 x g, and resuspended in FACS
buffer. Cell suspensions from liver were layered over Ficoll (Amersham
Pharmacia Biotech, Piscataway, NJ), and the mononuclear cell layer was
used for FACS analysis. We found that the treatments required to
dissociate these tissues did not affect CCR7 expression, and other
lymphocyte markers such as LFA-1 were positive on all isolated
lymphocyte populations (data not shown).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We tested the hypothesis (9, 17) that CCR7 expression (essential for homing of naive T-cells to secondary lymphoid tissues; Refs. 5, 6, 7) is lost in memory T cells that express adhesion receptors necessary for homing to nonlymphoid tissues. We generated two novel mAbs to human CCR7 (7H12 and 3D9, see Materials and Methods).
The best studied peripheral blood memory CD4 T cells dedicated to
specific nonlymphoid tissues are the skin-homing cells
(CLA(pos)/47(neg))
and the gut-homing cells
(CLA(neg)/47(pos))
(reviewed in Ref. 1). Four-color flow cytometry was used
to examine CCR7 expression on these two populations, as well as on
naive CD4 cells and
CLA(neg)/47(neg) or
double negative memory CD4 cells of unknown tissue-homing specificity
(Fig. 1
A). Naive and double
negative memory CD4 cells were nearly 100% positive for CCR7
expression (Fig. 1B). Skin- and gut-homing memory CD4 cells
were somewhat enriched in CCR7 cells (Fig. 1B), but the vast
majority of both populations were CCR7(pos). A survey of peripheral
blood CD4 subsets from 10 healthy donors (Fig. 1C) shows
that skin- and gut-homing populations were 
80% CCR7(pos), whereas
naive and double negative memory cells were nearly 100% CCR7(pos).
|
and SLC) was similar to their migration to SDF-1,
a nearly universal lymphocyte chemoattractant (11, 18)
(Fig. 1
D). Thus, the vast majority of naive, memory, and
tissue-dedicated CD4 cells from peripheral blood express CCR7, respond
to CCR7 ligands, and can probably home to secondary lymphoid
organs. CCR7 vs other markers on peripheral blood CD4 cells
As CCR7 loss correlated only poorly with expression of
tissue-dedicated homing receptors, we set out to identify other
features of CCR7(neg) CD4 T subsets. Fig. 2 shows flow cytometry of CCR7 vs several
other markers on CD4(pos) T cells from peripheral blood. As expected
from Fig. 1, the CCR7(neg) population contained subsets of CLA(pos) and
of
47high
cells (Fig. 2, top). All CCR7(neg) cells were contained
within the CD45RA(neg) memory population (Fig. 2, second row
left). Most CCR7(neg) cells lacked L-selectin, consistent with the
notion that these cells are incapable of homing to secondary lymphoid
organs (Fig. 2, third row left). Interestingly, CCR7(neg)
cells were nearly 100% positive for CCR5, the receptor for MIP-1,
RANTES, and several other CC chemokines (the anti-CCR5 mAb 2D7 was
used for these studies because it was shown to correlate best with
genetic expression of CCR5 when compared with other CCR5 mAbs; Ref.
19) (Fig. 2, third row right). Interestingly,
CCR7(neg) cells were also enriched in CD11b (MAC-1), a
2 integrin commonly expressed in the myeloid
lineages and B1 B cells found in serosal cavities, but rare on T
lymphocytes (Fig. 2, second row right). CCR7(neg) cells
often lacked CD27 (a member of the TNF- receptor family; Fig. 2, bottom). Moreover, over 50% of the CD27(neg) CD4 cells also
lacked CCR7.
|
The enrichment of CD27(neg) cells in the CCR7(neg) CD4 T cell
compartment was of great interest to us because CD27 loss has been
reported to mark both CD4 (20, 21) and CD8
(22) T cells of effector phenotype. As Sallusto et al. had
reported that the CCR7(neg) CD4 population is enriched in an
effector-like phenotype, we set out to more fully define the
relationship between CCR7 and CD27 expression on peripheral blood CD4
cells. Fig. 3A shows that
staining of CD4 cells with CD45RA and CD27 cleanly divides them into
three distinct subsets: CD45RA(pos)/CD27(pos) naive cells;
CD45RA(neg)/CD27(pos) conventional memory cells; and CD27(neg) memory
cells. Expression of CCR7, CCR5 (2D7), MAC-1, and L-selectin was
examined individually on each of these populations (Fig. 3B). Naive cells all expressed both L-selectin and CCR7,
consistent for their known tropism for secondary lymphoid tissues (Fig. 3A, top). Conventional memory cells contained a
subpopulation of CCR7(neg) and L-selectin(neg) cells, but the vast
majority was positive for both. Some conventional memory cells
expressed CCR5, and a very small number expressed MAC-1 (Fig. 3A, middle).
|
A, bottom).
Most CD27(neg) memory cells expressed neither CCR7 nor L-selectin. Many
of these cells expressed CCR5 and MAC-1, markers that were never seen
on naive cells. A survey of 10 healthy donors showed that CCR7(neg)
cells were quite rare (as a percentage) in the naive and conventional
memory subpopulations, but common within the CD27(neg) memory
population (Fig. 3C). Responsiveness to known CCR7 ligands
in chemotaxis assays correlated with CCR7 expression (Fig. 3D). Most naive and conventional memory cells responded well
to CCR7 ligands. Less than half of the CD27(neg) cells responded to
CCR7 ligands. All three populations respond equally well to SDF-1
(Fig. 3D, right). Diversity of memory CD4 cells lacking CCR7, CD27, or L-selectin
The above analysis of CD27(neg) memory cells shows them to be a
population greatly enriched in cells of unusual (presumptive lymphoid
tissue-excluded) phenotype. However, this observation is only part of
the story, and may be misleading. The relationship between CCR7 and
CD27 is only an enrichment, not a direct correlation. In fact, if we
stain peripheral blood CD4 cells for CCR7, CD27, and L-selectin
together (Fig. 4), we see that by gating
on either CCR7(neg), CD27(neg), or L-selectin(neg) cells, we enrich in
cells that are lacking either or both of the other two markers. Thus,
the message from these studies is that neither CCR7, CD27, nor
L-selectin define a distinct population. There is extreme diversity in
the cells lacking any one of these markers, whereas there is relative
uniformity among the majority of both memory and naive lymphocytes,
which express all three of these markers together.
|
We next examined the CCR7 expression of peripheral blood CD8 T
cell subsets. As mentioned above, CD45RA and CD27 can be used to
identify naive, memory, and effector CD8 subsets (22)
(Fig. 5A). CCR7 expression and
responsiveness to CCR7 ligands was tested on each of these peripheral
blood CD8 populations. Like naive CD4 cells, naive CD8 cells
(CD45RA(pos)/CD27(pos)) all expressed CCR7 and responded well to
MIP-3 and SLC (Fig. 5, B and C). The memory
CD8 population contained more CCR7(neg) than conventional memory CD4
cells (50%), which correlated well with their lower responsiveness
to CCR7 ligands.
|
(Fig. 5C,
right). CCR7 expression in tonsil T cell populations
As a representative secondary lymphoid organ for humans, tonsillar
T cells were examined for CCR7 expression. As in peripheral blood,
tonsil T cells can be divided into naive and memory based on CD45RA
expression. However, unlike peripheral blood, most CD45RA(neg) T cells
from the tonsil expressed the early activation marker CD69, suggesting
that they were in an activated state (Figs. 6A and 7A). Most
CD45RA(pos) naive tonsil T cells did not express CD69 (Figs. 6A and 7A).
|
), which may be unable to enter
secondary lymphoid organs because of their low CCR7 and L-selectin
levels.
|
B). The activated
CD4 T cells express CCR7, on average, at lower levels than naive cells,
and there was a large population of CCR7(neg) cells. Responsiveness to
CCR7 ligands again parallels CCR7 expression between naive and
activated cells (Fig. 6C). Another chemokine receptor, CXCR5
(BLR-1/EBI-2) has also been implicated in microenvironmental T cell
movements (24). Expression of CXCR5, originally cloned as
a B cell chemokine receptor, may allow activated T cells to migrate
into B cell zones to provide T cell help (25). We found
that expression of CXCR5 was nearly opposite to that of CCR7. Naive
tonsil cells expressed no CXCR5, whereas most activated cells expressed
CXCR5. In agreement with this, activated but not naive cells migrated
to the CXCR5 ligand BLC/BCA-1 (Fig. 6C). Both naive and
activated CD4 cells in the tonsil responded equally well to SDF-1
(Fig. 5C, right).
Tonsil CD8 cells.
Like CD4 cells, tonsil CD8 cells could be cleanly subdivided into
CD45RA(pos)/CD69(neg) naive and CD45RA(neg)/CD69(pos) activated subsets
(Fig. 7A). However, naive CD8 cells were much more abundant
than activated CD8 cells, unlike CD4 cells in which the naive and
activated populations were nearly equal (Fig. 4A). This is
consistent with the finding (Fig. 5) that a large proportion of memory
CD8 cells from peripheral blood do not express CCR7 (and CD8 effector
cells from blood are nearly devoid of CCR7) and thus may be unable to
home to secondary lymphoid organs. CCR7 and CXCR5 expression is similar
to that of the homologous CD4 populations. Naive cells express
uniformly high levels of CCR7 and no CXCR5. Activated CD8 cells are
heterogeneous for CCR7 expression and express CXCR5 (Fig. 7B). Responsiveness to chemokines again parallels receptor
expression (Fig. 7C).
CCR7 expression in T lymphocytes infiltrating nonlymphoid tissues
To further understand the role of CCR7 in routine lymphocyte
trafficking, immunosurveillance, and homing to inflamed sites, CCR7
expression was examined on tissue-infiltrating lymphocytes freshly
isolated from various nonlymphoid tissues. CD8 cells were rare in most
tissues examined, so our study focused on CD4 cells only. Contamination
of tissue-infiltrating lymphocytes with peripheral blood cells was not
significant, as naive cells, which constitute nearly 50% of peripheral
blood CD4 cells, were consistently absent from tissue populations (see
Figs. 1 and 3A).
Unlike CD45RA(neg) T cells from secondary lymphoid tissue (tonsil),
CD27(neg) cells were quite common in nonlymphoid
tissues. The ratio of CD27(neg) to CD27(pos) cells varied greatly
from tissue to tissue (Fig. 8) but was
similar among donors for a given tissue (data not shown). CD27(neg)
cells from all tissues were consistently CCR7(neg). The CD27(pos)
populations contained both CCR7(neg) and CCR7(pos) subsets.
|
).
Those isolated from normal skin (from face lifts, n =
3) and from synovium or synovial fluid of autoimmune arthritis patients
(n = 1 and 4, respectively) contained many more
CD27(neg)/CCR7(neg) than patient-matched blood (data not shown), but
the majority of infiltrating cells from these tissues were
CD27(pos)/CCR7(pos) (Fig. 8). |
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
CCR7 expression is not lost upon differentiation into skin- or gut-homing phenotypes. We have examined the expression and function of CCR7 in lymphocytes from peripheral blood, secondary lymphoid tissues, and nonlymphoid tissues. An existing hypothesis suggests that for a memory T cell to differentiate into a form capable of homing to nonlymphoid tissues, it must lose the ability (possessed by all naive T cells) to home to secondary lymphoid tissue via HEV (9, 17).
We have found that, like naive and most other memory T cells, the majority of tissue-specific memory T cells (i.e., skin- and gut-homing) still expressed CCR7, and are thus (because they also express L-selectin and LFA-1; Ref. 26) likely still competent to enter secondary lymphoid tissues. Skin- and gut-homing populations are moderately enriched in CCR7(neg) cells, indicating that loss of CCR7 may occur after differentiation into tissue-specific phenotypes or that these two differentiation processes may be entirely independent.
CCR7-negative peripheral blood CD4 cells. CCR7 was missing from only a minor subset of peripheral blood memory CD4 T cells. All naive T cells, and >90% of memory CD4 T cells (defined by CD45RA phenotype) expressed high levels of CCR7. The CCR7(pos) memory cells were relatively uniform in expression of L-selectin and CD27, like the naive population (although, of course, they aren’t uniform in homing receptor expression). Enrichment of CCR7(neg) cells in the CD27(neg) population was intriguing, and was examined in detail.
Memory T cells lacking CD27 have been previously associated with effector properties (20, 21, 22). We found that besides being enriched in CCR7(neg) cells, the CD27(neg) population of CD4 cells was also enriched in cells lacking L-selectin and in cells expressing MAC-1 and CCR5. At first, we proposed that because CCR7(neg) memory CD4 cells have been previously reported to contain a subset with a functional effector phenotype (27), CD27 negativity may define a uniform effector immunophenotype as suggested in Refs. 20, 21 . However, the CD27-negative population was not uniform with respect to CCR7 (or L-selectin expression). And, in fact, CD27, CCR7, or L-selectin could be used to identify small, diverse populations of cells, each enriched in cells negative for the other two markers, but each extremely heterogeneous. It remains to be seen whether CCR7, CD27, or L-selectin negativity will correlate best with the effector phenotype defined in Ref. (9) or whether (more likely) heterogeneity is in fact the essence of effector-memory cells.
Because these markers do not define a distinct phenotype as proposed in
Ref. 9 , we propose an alternative hypothesis. This
population may simply consist of cells that have recently been
activated and have not yet up-regulated the receptors necessary for
homing back to secondary lymphoid organs. This may be a defense
mechanism, preventing active cells (which are poised to secrete
activating cytokines) from entering lymphoid organs where they could
potentially cause unregulated activation of a large number of cells.
The expression patterns of CD27 and CCR7 on cells from nonlymphoid
tissues (discussed below) as well as the enrichment of CCR7(neg) cells
in the tissue-specific phenotypes (Fig. 1) are consistent with this
notion. Additional experiments will be required to resolve these
issues.
Peripheral blood CD8 T cells and CCR7 expression. We found that all naive CD8 cells (CD45RAhigh/CD27(pos)) expressed CCR7, whereas almost no effector-phenotype CD8 cells (CD45RA(pos)/CD27(neg)) expressed CCR7. The resting CD8 memory population (CD45RA(neg)/CD27(pos)) contained an intermediate level of CCR7-expressing cells. However, again, CD8 cells of effector phenotype could also consist of recently activated cells that have not yet regained the ability to traffic through lymphoid organs.
CCR7 in lymphocyte homeostasis and immunosurveillance
There have been three (nonexclusive) hypotheses for the roles of
CCR7 in lymphocyte homing to date: 1) recognition of SLC presented by
HEV of secondary lymphoid tissues, triggering arrest of circulating T
cells on endothelium as a prerequisite to migration into the tissue. In
this role, CCR7 would be an HEV homing receptor, along with L-selectin
and LFA-1. There is now ample support for this hypothesis in animal
models (5, 6 ; reviewed in Ref. 4); 2)
migration through gradients of MIP-3 expressed within secondary
lymphoid organs, which coordinates proper microenvironmental
localization within the organ. This hypothesis also has support in
animal models, as manipulation of CCR7 expression can alter the
microanatomic location of T cells within the spleen (23);
3) migration of tissue-infiltrating lymphocytes back into the lymphatic
system. This has been proposed because endothelial cells lining the
lymph vessels have been found to express mRNA for CCR7 ligands
(8). This hypothesis has not yet been tested for
lymphocytes in experimental models, but is supported by studies of DC
migration (27, 28, 29, 30, 31). We have examined CCR7 expression on T
cells derived from each of the locations where it is thought to have
influence (peripheral blood (discussed above), secondary lymphoid
tissue, and nonlymphoid tissue) to shed light on these
hypotheses.
Tonsil T cells. Secondary lymphoid tissues are very high-traffic zones for lymphocytes. T and B cells are constantly entering from the blood through HEV. Most cells entering lymphoid organs do not encounter their cognate Ag, and pass through the organ to return to the circulation via afferent lymph. However, those that do encounter Ag and become activated must be directed to microenvironmental locations where they can perform their helper or effector functions. It has been proposed that modulation of chemokine responses may mediate proper microenvironmental localization (25). We have found that CCR7 is expressed at high levels on naive T cells (both CD4 and CD8) within the tonsil, comparable to that of circulating naive cells. In contrast, many cells activated in the lymphoid organ may lose CCR7, which may allow them to enter microenvironments not normally entered by unactivated cells. Consistent with this notion, activated T cells gain the expression of CXCR5 (and perhaps other chemokine receptors not expressed by resting or naive cells), thus gaining the ability to respond to new chemotactic gradients not perceived by other cells. It is interesting that both CD4 and CD8 T cells undergo very similar changes in CCR7 and CXCR5 expression after activation; this strongly implies the participation of other chemokines in fine-tuning the microenvironmental localization of functionally distinct lymphocytes, as modeled in Refs. 32, 33). Our findings are consistent with the hypothesis that chemokine responsiveness patterns are actively altered in different subsets of lymphocytes, a mechanism that may orchestrate the complex interplay among APCs, T cells, and B cells within lymphoid organs.
Nonlymphoid tissues. Although naive T lymphocytes can be found almost exclusively in the blood and lymphoid organs, memory T cells can be found at low levels in every tissue of the body (34). We have examined the CCR7 expression of CD4 T cells isolated from several types of nonlymphoid tissues. One important finding from this work is that many tissue-infiltrating lymphocytes express CCR7. This further argues against the hypothesis that CCR7-expressing cells do not infiltrate nonlymphoid tissues (9, 17).
We have found a correlation between CCR7 and CD27 expression in
tissue-infiltrating lymphocytes, which parallels our findings in
peripheral blood. CD27 is a member of the TNF- receptor family, and
its modulation may mark previously unknown activation or developmental
states in tissue-infiltrating lymphocytes. However, loss of CD27
expression does not correlate well with expression of the activation
marker CD69, which is was generally expressed on all
tissue-infiltrating lymphocytes studied (data not shown).
Nearly all CD27(neg) tissue-infiltrating lymphocytes lacked CCR7
expression (Fig. 8). Lymphocytes from normal intestinal tissue, normal
lung, and cirrhotic liver are nearly all CD27(neg)/CCR7(neg).
Lymphocytes from normal skin and from synovium or synovial fluid of
rheumatoid arthritis-afflicted joints are more heterogeneous and
contain many CD27(pos)/CCR7(pos) cells.
Normal skin (with mostly CD27(pos)/CCR7(pos) memory cell infiltrates) and gut (with mostly CD27(neg)/CCR7(neg) memory infiltrates) are sites with very different levels of immunological activity. The gut tissue of normal individuals is thought to be constantly involved in immune reactions to food Ags and intestinal flora. This has led to the suggestion that intestinal tissue be considered a tertiary lymphoid organ (reviewed in Ref. 34). In contrast, skin presents a barrier to the outside world and would only engage in inflammatory reactions when the barrier is broken. Thus, normal skin would not be expected to contain much immune activity.
The patterns of CCR7 expression within these two (very different) tissues fits well with the notion that CCR7 ligands may direct tissue-infiltrating T cells back to the lymph (8). Based on the known levels of immune activity in these organs, CD27(neg) cells may represent a population that is actively engaged in Ag recognition. Therefore, this population is rare in skin but common in intestine. It would not be desirable for such actively engaged cells to return to the lymph; thus, these cells do not express CCR7. However, in the skin, where Ag recognition is not common, most lymphocytes are passing through the tissue in routine immunosurveillance, are not actively engaged in Ag recognition, and continue to express CD27. Such cells, not encountering Ag, continue to express CCR7 to guide them back to the lymph, completing their circuit through the tissue.
The arguments used above for gut-infiltrating lymphocytes would also
apply to lung and cirrhotic liver, whose infiltrating lymphocytes are
phenotypically similar to gut (Fig. 8). The high CCR7 expression in
rheumatoid synovium and synovial fluid requires another explanation:
perhaps an autoimmune chronically inflamed situation may greatly
enhance the amount of lymphocyte trafficking through the inflamed
tissue (with respect to its uninflamed counterpart). Only a small
proportion of cells passing through such a high-traffic area would be
specific for the autoantigen. Thus, just like normal skin, most cells
infiltrating rheumatoid arthritis synovium may not see Ag, and continue
to express CD27 and CCR7. Alternatively, the number of active cells in
synovium and synovial fluid samples could be lower due to
anti-inflammatory treatments the donors may have received.
Conclusions. In this study we 1) analyzed in detail the population of CCR7(neg) cells, which have been the focus of great interest recently; and 2) investigated the expression of CCR7 on cells at various points in the cycle of routine immunosurveillance in an attempt to shed light on the role of CCR7 and its ligands in these processes. We found that CCR7, CD27, and L-selectin, together with MAC-1 and CCR5, mark an intensely heterogeneous series of overlapping populations. No single one of these markers can be used to identify a uniform population with respect to the others. It is likely that a combination of these markers is required to identify all true effector memory cells.
We also found that the CCR7 expression patterns on T cells are consistent with known or hypothesized roles for each of the three major nexus points of immunosurveillance: trafficking into secondary lymphoid organs, movement and organization within lymphoid organs, and trafficking out of nonlymphoid organs and into the lymph.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. James J. Campbell, Assistant Professor of Pathology, Harvard Medical School; Children’s Hospital, Division of Transfusion Medicine, 300 Longwood Avenue, Room BD-401, Boston, MA 02115.
3 Please address mAB requests to L.W.
4 Abbreviations used in this paper: HEV, high endothelial venule(s); CXCR, CXC chemokine receptor; SDF, stromal cell-derived factor; MIP, macrophage-inflammatory protein; SLC, secondary lymphoid-tissue chemokine; BCA-1, Burkitt’s lymphoma receptor-1 ligand chemokine; CLA, cutaneous lymphocyte Ag; RA, rheumatoid arthritis.
Received for publication August 3, 2000. Accepted for publication October 20, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
receptor CCR7. J. Cell Biol. 141:1053.This article has been cited by other articles:
|
|
 |
|
  A. Miles, E. Liaskou, B. Eksteen, P. F. Lalor, and D. H. Adams CCL25 and CCL28 promote {alpha}4{beta}7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1257 - G1267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Verhoeven, S. Sankaran, M. Silvey, and S. Dandekar Antiviral Therapy during Primary Simian Immunodeficiency Virus Infection Fails To Prevent Acute Loss of CD4+ T Cells in Gut Mucosa but Enhances Their Rapid Restoration through Central Memory T Cells J. Virol., April 15, 2008; 82(8): 4016 - 4027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Santner-Nanan, N. Seddiki, E. Zhu, V. Quent, A. Kelleher, B. F. de St Groth, and R. Nanan Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype Int. Immunol., March 1, 2008; 20(3): 375 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Shiao, N. C. Kirkiles-Smith, B. R. Shepherd, J. M. McNiff, E. J. Carr, and J. S. Pober Human Effector Memory CD4+ T Cells Directly Recognize Allogeneic Endothelial Cells In Vitro and In Vivo J. Immunol., October 1, 2007; 179(7): 4397 - 4404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Onoda, M. Rahman, H. Nara, A. Araki, K. Makabe, K. Tsumoto, I. Kumagai, T. Kudo, N. Ishii, N. Tanaka, et al. Human CD4+ central and effector memory T cells produce IL-21: effect on cytokine-driven proliferation of CD4+ T cell subsets Int. Immunol., October 1, 2007; 19(10): 1191 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Raki, L.-E. Fallang, M. Brottveit, E. Bergseng, H. Quarsten, K. E. A. Lundin, and L. M. Sollid Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients PNAS, February 20, 2007; 104(8): 2831 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kaur, R. Saunders, P. Berger, S. Siddiqui, L. Woodman, A. Wardlaw, P. Bradding, and C. E. Brightling Airway Smooth Muscle and Mast Cell-derived CC Chemokine Ligand 19 Mediate Airway Smooth Muscle Migration in Asthma Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1179 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Soler, T. R. Chapman, L. R. Poisson, L. Wang, J. Cote-Sierra, M. Ryan, A. McDonald, S. Badola, E. Fedyk, A. J. Coyle, et al. CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes J. Immunol., November 15, 2006; 177(10): 6940 - 6951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ni, J. J. Campbell, G. Niehans, and B. Walcheck The Monoclonal Antibody CHO-131 Identifies a Subset of Cutaneous Lymphocyte-Associated Antigen T Cells Enriched in P-Selectin-Binding Cells J. Immunol., October 1, 2006; 177(7): 4742 - 4748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rinaldi, P. Gallo, M. Calabrese, F. Ranzato, D. Luise, D. Colavito, M. Motta, A. Guglielmo, E. Del Giudice, C. Romualdi, et al. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. Brain, August 1, 2006; 129(Pt 8): 1993 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Beyer, M. Kochanek, T. Giese, E. Endl, M. R. Weihrauch, P. A. Knolle, S. Classen, and J. L. Schultze In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma |
